Stone prevention: why so little progress?

被引:32
作者
Baumann, JM [1 ]
机构
[1] Reg Spital, Urol Abt, CH-2502 Biel, Switzerland
来源
UROLOGICAL RESEARCH | 1998年 / 26卷 / 02期
关键词
urolithiasis; stone metaphylaxis; urinary crystallization processes;
D O I
10.1007/s002400050027
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Despite intensive research the knowledge of stone pathogenesis, which is the basis of every rational stone metaphylaxis, has remained rather scanty. Epidemiology shows that stone formation in most patients is only a sporadic event, probably resulting from a coincidence of different factors. The hypercalciuria, hypocitraturia, hyperuricosuria and hyperoxaluria frequently found in calcium stone formers can be influenced therapeutically and, in affluent societies, seem to be the result of protein over-consumption. These four factors favour crystallization processes in urine. However, urine is normally protected from nucleation, growth and aggregation of calcium minerals by crystallization inhibitors. In urine, crystallization of calcium oxalate can only be induced by an extreme supersaturation, a deficient inhibitor activity and promoters of crystallization. To form a stone, crystals have to be retained in the urinary collecting system. Two mechanisms of retention are discussed: large crystal aggregates trapped in collecting ducts of renal papillae, or a pre-existing calcification of the papilla (mainly calcium phosphate) that may be responsible for growth of an initially fixed particle to a concretion large enough to become symptomatic. An excessive oxalate intake combined with a low calcium consumption can produce marked hyperoxaluria. In the animal model, hyperoxaluria induces not only calcium oxalate crystallization but also papillary damage and incrustrations. Hypercalciuria at a low pH favours the aggregation of calcium oxalate, and at a high pH the crystallization of calcium phosphate, a promoter of heterogeneous nucleation of calcium oxalate. All these factors and further complex phenomena mentioned in this paper have to be taken in account to perform rational stone metaphylaxis.
引用
收藏
页码:77 / 81
页数:5
相关论文
共 51 条
  • [1] ACHILLES W, 1995, UROLITHIASIS CONSENS, P5
  • [2] ACKERMANN D, 1987, UROL RES, V15, P63
  • [3] RECURRENCES DURING A 10-YEAR FOLLOW-UP AFTER 1ST RENAL STONE EPISODE
    AHLSTRAND, C
    TISELIUS, HG
    [J]. UROLOGICAL RESEARCH, 1990, 18 (06): : 397 - 399
  • [4] ANDERSEN DA, 1969, RENAL STONE RES S, P7
  • [5] BAUMANN JM, 1985, UROL RES, V13, P169
  • [6] BAUMANN JM, 1984, FORTSCHR UROL NEPHRO, V22, P151
  • [7] BAUMANN JM, 1990, UROL RES S, V18, P25
  • [8] BAUMANN JM, 1997, IN PRESS SCANNING MI
  • [9] BAUMANN JM, 1997, IN PRESS UROL INT
  • [10] BOULAHROUZ R, 1997, RENAL STONE DIS, P6